ISRG vs RMD — Key Metrics
| Metric | ISRG (INTUITIVE SURGICAL INC) | RMD (RESMED INC) |
|---|---|---|
| Price | 420.95 | 242.61 |
| Market Cap | 145.92 Billion | 34.12 Billion |
| P/E (TTM) | 50.41 | 22.04 |
| P/B (Quarterly) | 9.283 | 5.438 |
| P/S (TTM) | 12.6 | 5.95 |
| Net Profit Margin (TTM) | 25.5 | 27.8 |
| Gross Margin (TTM) | 67.2 | 61.1 |
| ROE (TTM) | 17.0 | 25.1 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: RMD.
Financial Metrics
| ISRG | Metrics | RMD |
|---|---|---|
| $420.95 | Price | $242.61 |
| — | Market Capitalization | — |
| 50.41 | Price to Earnings Ratio | 22.04 |
| 12.6 | Price to Sales | 5.95 |
| 40.04 | Price to FCF Ratio | 21.21 |
| 18.76 | Price to Gross Profit | 9.75 |
| 97.69 | Price to R&D | 86.65 |
| 17.31 | Price to Current Assets | 9.73 |
ISRG vs RMD at a glance
Intuitive Surgical INC (ISRG) and Resmed INC (RMD) are both Medical Instruments & Supplies companies in the Healthcare sector. ISRG is the larger, at $145.9 billion in market value against $34.1 billion for RMD, about 4.3 times the size.
On trailing-twelve-month figures, ISRG trades at 50.4 times trailing earnings and RMD at 22.0; net profit margins are 25.5% and 27.8%.
The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.